Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesamorelin for HIV-associated abdominal fat accumulation
NCT00123253Phase 3Completed
- Sponsor
- Theratechnologies Inc.
- Start
- Jun 2005
- Primary completion
- Nov 2006
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 3 trial of tesamorelin in HIV-associated lipodystrophy (HALS), sponsored by Theratechnologies Inc.. Started Jun 2005; status: completed.
02
Drugs
tesamorelin
03
Conditions
HIV-associated lipodystrophy (HALS)
Beyond the preview
Go deeper on NCT00123253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123253.